In a retrospective study, Lyons et al., evaluated the effects of semaglutide in 30 obese patients with HS, reporting reductions in weight, BMI, and metabolic markers such as HbA1c, along with improvements in DLQI and a decreased frequency of flares [160]
What is generic semaglutide, and how does it compare to Ozempic
Avoid Excessively Rapid Weight Loss A slower, steady rate reduces the risk of Telogen Effluvium
Complete and submit the report online at MedWatch: The FDA Safety Information and Adverse Event Reporting Program, or Download and complete the form, then submit it via fax at 1-800-FDA-0178
These patterns often reflect underlying hormonal or metabolic shifts that standard screenings may not fully assess
Our program is designed for adults ready to approach weight loss with a practical, wellness-centered mindset